Discovery of novel quinazoline derivatives bearing semicarbazone moiety as potent EGFR kinase inhibitors-Reference-Cited by-同舟云学术

Discovery of novel quinazoline derivatives bearing semicarbazone moiety as potent EGFR kinase inhibitors

Published:2018 Issue: Volume:16 Page:462-478
ISSN:2001-0370
Container-title:Computational and Structural Biotechnology Journal
language:en
Short-container-title:Computational and Structural Biotechnology Journal

Author:

Tu Yuanbiao,Wang Caolin,Yang Zunhua,Zhao Bingbing,Lai Luogen,Yang Qi,Zheng Pengwu,Zhu Wufu^ORCID

Funder

The National Natural Science Funds of China

Natural Science Foundation of Jiangxi

Natural Science Foundation of Jiangxi, China

Jiangxi Science & Technology Normal University

Publisher

Elsevier BV

Subject

Computer Science Applications,Genetics,Biochemistry,Structural Biology,Biophysics,Biotechnology

Reference23 articles.

1. Epidermal growth factor receptor mutations in lung cancer;Sharma;Nat Rev Cancer,2007

2. Advances of AKT pathway in human oncogenesis and as a target for anti-cancer drug discovery;Cheng;Curr Cancer Drug Targets,2008

3. Challenges and perspectives on the development of small-molecule EGFR inhibitors against T790M-mediated resistance in non-small-cell lung cancer;Song;J Med Chem,2016

4. Epidermal growth factor receptor (EGFR) mutation analysis, gene expression profiling and EGFR protein expression in primary prostate cancer;Peraldoneia;BMC Cancer,2011

5. FDA drug approval summary: gefitinib (ZD1839) (iressa) tablets;Cohen;Oncologist,2003

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synergistic effect of sorafenib with Platycladus orientalis (L) leaf extract on cervical cancer;Bioscience Journal;2023-01-27

2. Pyrrole‐based EGFR inhibitors for the treatment of NCSLC : Binding modes and SARs investigations;Chemical Biology & Drug Design;2022-11-17

3. Targeting EGFR Tyrosine Kinase: Design, Synthesis and Biological Evaluation of Novel Quinazolinone Derivatives;Iranian Journal of Pharmaceutical Research;2022-03-08

4. Novel quinazoline-based EGFR kinase inhibitors: A review focussing on SAR and molecular docking studies (2015-2019);European Journal of Medicinal Chemistry;2020-10

5. Synthesis and screening of novel anthraquinone−quinazoline multitarget hybrids as promising anticancer candidates;Future Medicinal Chemistry;2020-01